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Abstract
Background: The aim was to determine the incidence of seed migration not only to the chest, but also to the
abdomen and pelvis after transperineal interstitial prostate brachytherapy with loose
125I seeds.
Methods: We reviewed the records of 267 patients who underwent prostate brachytherapy with loose
125I seeds.
After seed implantation, orthogonal chest radiographs, an abdominal radiograph, and a pelvic radiograph were
undertaken routinely to document the occurrence and sites of seed migration. The incidence of seed migration to
the chest, abdomen, and pelvis was calculated. All patients who had seed migration to the abdomen and pelvis
subsequently underwent a computed tomography scan to identify the exact location of the migrated seeds.
Postimplant dosimetric analysis was undertaken, and dosimetric results were compared between patients with and
without seed migration.
Results: A total of 19,236 seeds were implanted in 267 patients. Overall, 91 of 19,236 (0.47%) seeds migrated in 66
of 267 (24.7%) patients. Sixty-nine (0.36%) seeds migrated to the chest in 54 (20.2%) patients. Seven (0.036%) seeds
migrated to the abdomen in six (2.2%) patients. Fifteen (0.078%) seeds migrated to the pelvis in 15 (5.6%) patients.
Seed migration occurred predominantly within two weeks after seed implantation. None of the 66 patients had
symptoms related to the migrated seeds. Postimplant prostate D90 was not significantly different between patients
with and without seed migration.
Conclusion: We showed the incidence of seed migration to the chest, abdomen and pelvis. Seed migration did
not have a significant effect on postimplant prostate D90.
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Background
Seed migration is a well-recognized event that occurs
after transperineal interstitial prostate brachytherapy, and
it is observed more often with loose seeds than with
linked seeds [1-5].
It is well known that the most frequent site of seed
migration is the chest. The American Brachytherapy
Society has advised that a chest radiograph should be
undertaken at the first follow-up visit to scan the lungs
for embolized seeds [6]. Consequently, the incidence of
seed migration to the chest has been well reported
[1,2,4,5,7-19]. However, documentation of the incidence
of seed migration to the abdomen and pelvis is rare. Rare
cases of seed migration to a coronary artery, the right
ventricle, the liver, the kidneys, Batson’s vertebral venous
plexus, and the left testicular vein have been reported
[20-26]. However, it has never been fully determined
whether seed migration to these locations is really rare.
T h ep r i m a r yp u r p o s e so ft h ep r e s e n ts t u d yw e r et o
determine the incidence of seed migration not only to
the chest, but also to the abdomen and the pelvis at our
institution and to identify the exact location of the seeds
that had migrated to the abdomen and pelvis with com-
puted tomography (CT). The secondary purpose was to * Correspondence: h4411@wave.plala.or.jp
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dosimetry.
Methods
We reviewed the records of 267 patients who underwent
transperineal interstitial prostate brachytherapy with loose
125I seeds for clinical T1/T2 prostate cancer at our institu-
tion. Table 1 details the characteristics of all 267 patients.
Two patients (0.75%) received brachytherapy plus external
beam radiotherapy (45 Gy in 1.8 Gy fractions). One hun-
dred twenty-three of the 267 (46.1%) patients also under-
went neoadjuvant hormonal therapy (NHT), which
consisted of luteinizing hormone-releasing hormone ago-
nist and antiandrogens. NHT was generally undertaken in
p a t i e n t sw i t hap r o s t a t ev o l u m e> 4 0c co rt h o s ew i t h
pubic arch interference by transrectal ultrasound (TRUS)
at the preimplant volume study [27].
One month before seed implantation, a preplan was
obtained with TRUS images taken at 5 mm intervals from
the base to the apex of the prostate with the patient in the
dorsal lithotomy position. The planning target volume
included the prostate gland, with a margin of 3 mm ante-
riorly and laterally and 5 mm in the cranial and caudal
directions. No margin was added posteriorly at the rectal
interface. Treatment planning used a peripheral or a modi-
fied peripheral approach. For the 265 patients who
received brachytherapy alone, the prescribed brachyther-
apy dose was 145 Gy and 160 Gy for the first 163 patients
and the subsequent 102 patients, respectively. For the
remaining two patients who received brachytherapy plus
external beam radiotherapy, the prescribed brachytherapy
dose was 110 Gy. TG 43 formalism was used in the pre-
planning and postimplant dosimetry analyses [28]. All 267
patients were treated with loose
125I radioactive seeds with
a Mick applicator (Mick Radio-Nuclear Instruments,
Bronx, NY). To ensure that no seeds were left in the blad-
der, postoperative fluoroscopic images were obtained.
Prior to discharge, postoperative surveys of voided urine
w e r ec o n d u c t e dt od e t e c tv o i d e ds e e d s .
Orthogonal chest radiographs, an abdominal radio-
graph, and a pelvic radiograph were undertaken to docu-
ment the occurrence and sites of seed migration one day
after seed implantation. These follow-up radiographs
were undertaken routinely at each outpatient visit.
Patients returned to our outpatient clinic two weeks and
three months after seed implantation, then at three-
month intervals for the first three years and at six-month
intervals thereafter. Seed migration to the chest and the
abdomen was recorded when one or more seeds were
visualized on orthogonal chest radiographs and the ante-
roposterior (AP) abdominal radiograph, respectively.
Seed migration to the pelvis was recorded when one or
more seeds were separated from the main seed cluster on
an AP pelvic radiograph. However, seeds placed into the
bladder and the seminal vesicles or seeds placed inferior
to the prostate by mistake were not scored as migrated.
Seeds voided in the urine were not scored as migrated.
Subsequently, all patients who had seed migration to the
abdomen and pelvis underwent a CT scan to identify the
exact location of the migrated seeds. The incidence of
seed migration to the chest, abdomen, and pelvis was
calculated.
Postimplant dosimetric analysis by CT was performed
one month after seed implantation. The seed count in the
region of the prostate gland was determined on the AP
pelvic radiographs obtained two weeks after seed implan-
tation. The postimplant prostate D90 (the dose received
by 90% of the volume of the prostate) value was compared
between patients with and without seed migration. Statisti-
cal analysis was performed with Student’s t-test. A p value
of <0.05 was considered statistically significant.
Results
In total, 19,236 seeds were implanted in 267 patients.
All 267 patients underwent follow-up radiographs. Med-
ian follow-up was 41 months (range, 8.5-76 months).
At one day after seed implantation, follow-up radio-
graphs demonstrated that 41 of the 19,236 (0.21%) seeds
migrated in 37 of the 267 (13.9%) patients: three seeds in
one patient, two seeds in each of two patients, and a sin-
gle seed in each of the remaining 34 patients. Fifteen
(0.078%) seeds migrated to the chest in 15 (5.6%)
patients. One (0.0052%) seed migrated to the abdomen in
one (0.37%) patient. Twenty-five (0.13%) seeds migrated
to the pelvis in 23 (8.6%) patients.
At two weeks after seed implantation, 85 of the 19,236
(0.44%) seeds migrated in 61 of the 267 (22.8%) patients:
seven seeds in one patient, three seeds in each of four
patients, two seeds in each of 10 patients, and a single
seed in each of the remaining 46 patients. Sixty-one
(0.32%) seeds migrated to the chest in 48 (18.0%)
patients. Seven (0.036%) seeds migrated to the abdomen
Table 1 Patient Characteristics (N = 267)
Variable Value Range
Age (y) 68.7 ± 0.4 (53-81)
Initial PSA (ng/mL) 7.36 ± 0.20 (4.01-19.88)
Gleason score < 7, n (%) 172 (64.4)
Gleason score = 7, n (%) 95 (35.6)
Preimplant prostate volume by TRUS (cc) 23.5 ± 0.4 (9.3-41.0)
Total radioactivity (MBq) 922.3 ± 10.3 (482.9-1300.5)
Number of seeds implanted 72.0 ± 0.7 (40-100)
Number of needles 24.9 ± 0.3 (12-39)
Data are presented as mean ± standard error (range) or number (percent) of
patients.
Abbreviations: PSA = prostate-specific antigen; TRUS = transrectal ultrasound
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to the pelvis in 16 (6.0%) patients.
At three months after seed implantation, 87 of the
19,236 (0.45%) seeds migrated in 63 of the 267 (23.6%)
patients: seven seeds in one patient, three seeds in each of
four patients, two seeds in each of 10 patients, and a single
seed in each of the remaining 48 patients. Sixty-three
(0.33%) seeds migrated to the chest in 50 (18.7%) patients.
Seven (0.036%) seeds migrated to the abdomen in six
(2.2%) patients. Seventeen (0.088%) seeds migrated to the
pelvis in 16 (6.0%) patients.
Although seed migration occurred predominantly within
two weeks after seed implantation, eventually, six seeds
were found to migrate or relocate to the chest long after
seed implantation: four seeds were found to have migrated
to the chest at a median of 27 months (range 9.1-16
months), and two seeds were found to have relocated
from the pelvis to the chest at 6.1 and 48 months after
seed implantation, respectively. In these patients, follow-
up radiographs were undertaken routinely at every outpa-
tient visit; however, migration or relocation of these seeds
was not found at the previous visit. Meanwhile, no seed
relocation from the chest to other sites was observed in
the present study.
Eventually, 91 of the 19,236 (0.47%) seeds migrated in 66
of the 267 (24.7%) patients: seven seeds in one patient,
three seeds in each of five patients, two seeds in each of
nine patients, and a single seed in each of the remaining
51 patients. Sixty-nine (0.36%) seeds migrated to the chest
in 54 (20.2%) patients. Seven (0.036%) seeds migrated to
the abdomen in six (2.2%) patients. Fifteen (0.078%) seeds
migrated to the pelvis in 15 (5.6%) patients. All 66 patients
were informed of seed migration; none of these patients
had symptoms related to the migrated seeds.
Seeds that migrated to the abdomen (seven seeds in six
patients)
Two of the 19,236 (0.010%) seeds migrated to the liver in
two of the 267 (0.75%) patients: a single seed migrated to
the liver in each of two patients. Five (0.026%) seeds
migrated to the kidneys in four (1.5%) patients: two seeds
migrated to the same kidney in one patient, and a single
seed migrated to the kidney in each of the remaining three
patients. In one patient (Case 1), one day after seed
implantation, an abdominal radiograph showed that a seed
had migrated to the right side of the middle abdomen,
which was considered to be separated from the inferior
vena cava (IVC) (Figure 1A). However, two weeks after
seed implantation, an abdominal radiograph showed that
the seed had disappeared from the right side of the middle
abdomen, and showed a seed that had migrated to the left
side of the middle abdomen (Figure 1B). On pelvic radio-
graphs, there were no changes in number of seeds that
had been implanted into the prostate between one day
and two weeks after seed implantation. It was concluded
that the seed had relocated from the right side of the mid-
dle abdomen to the left side of the middle abdomen. A
subsequent abdominal CT demonstrated that the seed had
migrated to the left kidney (Figure 1C). In another patient
(Case 2), two weeks after seed implantation, an abdominal
radiograph showed that two seeds had migrated to the
same right kidney (Figure 2A-C).
Seeds that migrated to the pelvis (15 seeds in 15
patients)
A single seed migrated to the pelvis in each of 15
patients. Five of the 19,236 (0.026%) seeds migrated to
Batson’s vertebral venous plexus in five of the 267
(1.9%) patients. Four (0.021%) seeds migrated to the
sacral venous plexus in four (1.5%) patients. Two
(0.010%) seeds migrated to the iliac veins in two (0.75%)
patients. Two (0.010%) seeds migrated to the right
ischial bone in two (0.75%) patients. Two (0.010%) seeds
migrated to the obturator internus muscles in two
(0.75%) patients.
Seed relocation four years after seed implantation
In one patient (Case 3), seed relocation was found four
years after seed implantation. A seed had migrated to
the right groin area one day after seed implantation
(Figure 3A-B). Three years and six months after seed
implantation, a pelvic radiograph showed that the seed
was in the same location. However, four years after seed
implantation, a pelvic radiograph showed that the seed
had disappeared from the right groin area (Figure 3C),
and a chest radiograph showed a seed that had migrated
to the left lung, which was not found at three years and
six months after seed implantation. It was concluded
that the seed had initially lodged in a branch of the
right femoral vein, and then relocated to the left lung
through the IVC, long after seed implantation.
Postimplant dosimetric analysis
In the 265 patients who received brachytherapy alone,
the postimplant prostate D90 was 175.0 ± 1.3 Gy (mean
± standard error [SE]). In these 265 patients, the post-
implant prostate D90 value was not significantly differ-
ent between patients with and without seed migration
(mean ± SE, 175.1 ± 2.3 Gy vs. 175.0 ± 1.5 Gy, respec-
tively, p = 0.992). In 15 patients who had multiple
migrated seeds, the postimplant prostate D90 ranged
from 137.2 to 198.5 Gy (mean ± SE, 171.8 ± 5.5 Gy),
which was not significantly different from that in
patients without seed migration (p = 0.573).
In the remaining two patients who received bra-
chytherapy plus external beam radiotherapy, the postim-
plant prostate D90 values were 116.4 Gy and 132.6 Gy.
These two patients had no seed migration.
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Incidence of seed migration
We found that 0.36% of implanted seeds migrated to the
chest in 20% of our patient population, similar to previous
reports (Table 2). It has been reported that the incidence
of seed migration to the chest can be as high as 55% per
patient population and 0.98% per number of implanted
seeds (Table 2) [9]. The variability of the incidence of seed
migration to the chest among the reported results is con-
sidered to be attributed to different types of seeds (linked
or loose), different designs of seed placement (intrapro-
static or extraprostatic), different timings of follow-up
radiographs, and different protocols of follow-up chest
radiographs (orthogonal or AP alone) (Table 2) [1-5,9,13].
In contrast, the incidence of seed migration to the
abdomen and pelvis has been reported rarely (Table 2). A
possible reason is that the American Brachytherapy
Society does not specifically recommend follow-up
abdominal and pelvic radiographs after seed implantation
[6]. Therefore, in most institutions, follow-up abdominal
and pelvic radiographs would not be undertaken routi-
nely. However, we found that seed migration to the abdo-
men and pelvis occurred in 2.2% and 5.6%, respectively,
of our patient population. Although the incidence of seed
migration to the abdomen and pelvis is lower than that
of seed migration to the chest, we would consider it advi-
sable to undertake follow-up abdominal and pelvic radio-
graphs after seed implantation.
The dynamics of seed migration to the chest
One day, two weeks, and three months after seed implan-
tation, follow-up chest radiographs showed 22%, 88%,
and 91%, respectively, of 69 seeds that eventually
migrated to the chest. These results mean that 22%, 66%,
and 2.9% of these 69 seeds migrated to the chest within
one day, between one day and two weeks, and between
two weeks and three months after seed implantation,
respectively. About 90% of these 69 seeds migrated to the
chest within two weeks after seed implantation. These
results are similar to a previous report [13]. Merrick et al.
Figure 1 Case 1: Relocation from the right side of the middle abdomen to the left kidney. One day after seed implantation, a follow-up
abdominal radiograph showed that a seed had migrated to the right side of the middle abdomen (solid arrow) (A). Two weeks later, the seed
had relocated from the right side of the middle abdomen to the left side of the middle abdomen (solid arrow) (B). Subsequent computed
tomography showed that the seed had migrated to the left kidney (solid arrow) (C).
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most likely to occur between 14 and 28 days after seed
implantation [13]. Although we observed that several
seeds migrated to the chest more than six months after
seed implantation, this finding should be considered
exceptional. Therefore, it is suggested that follow-up
chest radiographs should be undertaken two weeks, or
preferably a few months, after seed implantation to detect
most seeds that will migrate to the chest.
Seed migration to the kidneys and Batson’s vertebral
plexus is not very rare
The results of the present study show a total of four and
five cases of seed migration to the kidneys and Batson’s
vertebral venous plexus, respectively, at only one institu-
tion, which suggests that such cases are not very rare.
Meanwhile, in previous studies, a total of only four and
four cases of seed migration to the kidneys and Batson’s
vertebral venous plexus, respectively, have been reported
as rare cases, which is in disagreement with our conclu-
sion [22,23,26,29]. The same number or more cases of
seed migration to these areas were found in our single
study compared with all previous studies. A possible
explanation is that, in the present study, orthogonal chest
radiographs, an abdominal radiograph, and a pelvic radio-
graph were undertaken routinely to detect seed migration
to the chest, abdomen, and pelvis at several time points
after seed implantation. Moreover, in all patients who had
seed migration to the abdomen and pelvis, a CT scan was
undertaken to identify the exact location of the migrated
seeds. Consequently, more cases of seed migration to the
kidneys and Batson’s vertebral venous plexus were found
in the present study. We speculate that some seed migra-
tion to the kidneys and Batson’s vertebral venous plexus
might have gone undetected in other institutions.
In some cases of seed migration to the kidneys, the
mechanism is difficult to explain
Previous investigators have explained seed migration to
the kidneys as follows: migrated seeds in venous vessels
would enter the systemic circulation through a right-to-
left shunt, such as a patent foramen ovale or pulmonary
Figure 2 Case 2: Migration of two seeds to the same right kidney. Two weeks after seed implantation, a follow-up abdominal radiograph
showed that two seeds had migrated to the right side of the middle abdomen (solid arrows) (A). Subsequent computed tomography showed
that these two seeds had migrated to the same right kidney (solid arrows) (B,C).
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branch of the renal arteries [26]. We call this route of seed
migration through a right-to-left shunt “a paradoxical
route.”
The present study has provided some interesting cases
of seed migration to the kidneys, the mechanism of which
is difficult to explain. In Ca s e1o ft h ep r e s e n ts t u d y ,a
seed had migrated to the right side of the middle abdo-
men, which was considered to be separated from the IVC,
and then had relocated to the left kidney (Figure 1A-C). If
the seed had initially embolized to an artery of the right
side of the middle abdomen, such as a branch of the right
renal artery, through a paradoxical route, it is difficult to
explain how the seed would have relocated to the left kid-
ney. In Case 2, two seeds had migrated to the same right
kidney (Figure 2A-C). The mechanism of seed migration
t ot h ek i d n e yt h r o u g hap a r a d o x i c a lr o u t ei st o oc o m p l i -
cated. Therefore, it is highly unlikely that two seeds would
happen to migrate to the same right kidney through a
paradoxical route by chance, although the possibility can-
not be completely excluded. Other possible mechanisms
should be proposed to explain how seed migration to the
kidneys would have occurred in the two cases mentioned
above.
Other possible mechanisms of seed migration
We assume that seed movement in venous vessels would
reflect not only the force of the blood flow but also the
force of gravity, and that a seed sometimes would move
in venous vessels against the blood flow, because the
gravity could overcome the blood flow. The explanation
is as follows. Intravascular missile migration following
gunshot injury has been reported [30-34]. A missile
sometimes moves in a retrograde fashion against the nor-
mal blood flow in major venous vessels including the
IVC, and sometimes lodges in the renal vein and the
hepatic vein [30-34]. It has been postulated that missile
migration against the blood flow in venous vessels could
occur because of gravity, the patient’s position (upright)
at the moment of wounding and/or positional changes of
the body, the weight and shape of the missile, and possi-
ble low flow states [30]. Although the size and the weight
Figure 3 Case 3: Seed disappearance from the right groin area four years after seed implantation. One day after seed implantation, a
follow-up pelvic radiograph showed that a seed was located inferior to the right side of the pelvis (solid arrow) (A). Subsequent computed
tomography showed that the seed had migrated to the right groin area (solid arrow) (B). Four years after seed implantation, a follow-up pelvic
radiograph showed that the seed had disappeared from the pelvic area (C).
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Page 6 of 10Table 2 Literature Survey of Seed Migration
Patients with seed migration Seed migration rate
Study [ref.] Isotope Loose or linked Number % Number % Location Timing of radiographs
Kumar et al. [11]
125I Linked 0/14 0.0
Steinfeld et al. [17]
125I Loose 1/5 20.0 5/600 0.80 Chest
Grimm et al. [10]
125I/
103Pd Loose 39/221 17.6 Chest The day of implant
Nag et al. [14]
103Pd Loose 6/30 20.0 7/3213 0.22 Chest The day of implant or the next follow-up visit (< 1 year)
Nag et al. [15]
103Pd Loose 19/107 17.8 32/10612 0.30 Chest Median of 30 days
Tapen et al. [5]
125I Linked* 1/143 0.7 Chest The day of implant
125I Loose 1/10 10.0 Chest The day of implant
103Pd Loose 15/136 11.0 Chest The day of implant
Overall 17/289 5.9 Chest The day of implant
Merrick et al. [13]
125I Linked/loose† 18/84 21.4 24/13467 0.18 Chest <14 days, or >30 days ††
103Pd loose 16/72 22.2 29/10338 0.28 Chest <14 days, or >30 days §
Overall 34/156 21.8 53/23805 0.22 Chest <14 days, or >30 days ||
Older et al. [16]
103Pd Loose 32/110 29.0 Chest Median of 3 months
Ankem et al. [7]
125I/
103Pd Loose 21/58 36.2 34/4755 0.72 Chest Median of 45 days
Eshleman et al. [9]
125I/
103Pd Loose 55/100 55.0 119/12135 0.98 Chest 2-3 month
Al-Qaisieh et al. [1]
125I Linked 0/100 0.0 Chest Median of 53 days
Chauveinc et al. [8]
125I Loose 27/170 16.0 32/12179 0.26 Chest 2 months
Kunos et al. [12]
125I/
103Pd Loose 43/120 35.8 68/12524 0.54 Chest Median of 133 days
125I/
103Pd Loose 41/12524 0.33 Pelvis
Fuller et al. [2]
125I/
103Pd Loose 9/37 24.0 11/5688 0.193 Chest 3-12 months
125I/
103Pd Loose 2/37 5.4 2/5688 0.035 Pelvis
125I/
103Pd Linked¶ 0/23 0.0 0/4018 0.0 Chest
125I/
103Pd Linked¶ 0/23 0.0 0/4018 0.0 Pelvis
Stone et al. [18]
125I Loose 4/146 2.7 Chest Median of 30 months
103Pd Loose 0/92 0.0 Chest
Overall 4/238 1.7 10/21654 0.046 Chest
Saibishkumar et al. [4]
125I Loose 4/20 20.0 5/2160 0.23 Chest 1 month
125I Linked 0/20 0.0 0/2236 0.0 Chest
Sugawara et al. [19]
125I Loose 33/11240 0.29 Chest 3 months
125I Loose 3/11240 0.027 Abdomen
125I Loose 10/11240 0.089 Pelvis
Overall 35/158 22.2 46/11240 0.41
Present series
125I Loose 54/267 20 69/19236 0.36 Chest Median of 41 months
125I Loose 6/267 2.2 7/19236 0.036 Abdomen
125I Loose 15/267 5.6 15/19236 0.078 Pelvis
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0Table 2 Literature Survey of Seed Migration (Continued)
Overall 66/267 25 91/19236 0.47
*Linked seeds were restricted to needles placed at the periphery of the prostate implant. All seeds placed centrally, close to the urethra, were loose seeds. On average, 8-10 loose seeds were used.
†Of the total
125I seeds, 64% were linked seeds. Linked seeds were limited to the region of the capsule/periprostatic region. Loose seeds were utilized in the central aspect of the gland.
††9 patients, within 14 days; 75 patients, more than 30 days.
§11patients within 14 days; 61patients, more than 30 days.
||Of the 20 patients who had postimplant chest radiographs obtained within 14 days of brachytherapy, none had seeds detected in the lungs. Categorizing patients by isotope, for
125I, 18/75 (24.0%) and for
103Pd,
16/61 (26.2%) with chest radiographs beyond 30 days had seeds found in the lungs.
¶A mixture of linked and free seeds, with a median 74% of needles per case containing seeds in linked, with central and posterior needles typically containing loose seeds.
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125I radioactive seed (4.5 mm in length, 0.8 mm in
diameter, and about 10 mg in weight per seed) are smal-
ler than those of a bullet, it is considered that a seed
could move against the blood flow in major venous ves-
sels because of gravity. The reasons are as follows. The
specific gravity of the seed (about 4 g/mL) is much higher
than that of blood, and the seed is less water resistant
because of its rod-shaped structure. In addition, a seed
would usually be located near the wall of major venous
vessels due to gravity and the patient’sp o s i t i o n ,a n d
therefore, a seed would be affected by a relatively slow
stream of blood near the vascular wall compared with
that in the center of major venous vessels. It is known
that in major venous vessels, the blood flow is generally
laminar, and the distribution of velocity across the tube is
parabolic [35]. Therefore, the velocity of blood flow
decreases from the center toward the wall of the venous
vessel tube [35].
The mechanism of seed migration to various sites could
be explained by the assumption that a seed could move in
major venous vessels against the blood flow by gravity. In
the present cases, seed migration to the kidneys, the liver,
and the right groin area (probably a branch of the right
femoral vein) (Case 3) would have occurred in venous ves-
sels, partially in a retrograde fashion by gravity, without
being passed through a paradoxical route. This explana-
tion does not require the assumption that a patient would
have a right-to-left shunt.
Influence of seed migration on postimplant dosimetry
The postimplant prostate D90 was not significantly differ-
ent between patients with and without seed migration.
Moreover, in 15 patients who had multiple migrated seeds,
the postimplant prostate D90 was relatively acceptable, and
no supplemental seed implantation was required. These
results indicate that seed migration did not have a signifi-
cant effect on postimplant prostate dosimetry in the present
study. Possible reasons are as follows. First, in most patients
with seed migration, only one or two seeds had migrated,
which would have less effect on the dosimetry of the pros-
tate. Tapen et al. have suggested that the loss of a few seeds
may not have a significant effect on dose homogeneity or
total dose to the prostate [5]. Second, seed migration would
have much less effect on the dosimetry of the prostate than
other mechanisms of seed loss, such as seed misplacement
to the seminal vesicle or perineum and being voided in the
urine postoperatively. Merrick et al. have reported that seed
migration to the chest accounted for only 10% of total seed
loss from the prostate region, highlighting the importance
of other mechanisms of loss [13].
Seed migration-related sequelae
In the present study, none of the 66 patients had symp-
toms related to the migrated seeds. Although it has
been reported that most patients with seed migration
are asymptomatic, there have been a few reports of seed
migration-related sequelae, such as a few anecdotal
instances of cardiac arrhythmia, myocardial infarction,
and radiation pneumonitis [21,36,37]. Therefore, it is
important to try to reduce the incidence of seed migra-
tion. The use of seeds linked with an absorbable suture
material has been associated with a dramatically
decreased rate of seed migration, although a potentially
higher risk of radiotoxicity to the urethra and rectum
has been pointed out [1,3,5,38]. In our study, linked
seeds were not administered, because they are not com-
mercially available in our country at present.
Conclusions
In the present study, we determined the incidence of
seed migration not only to the chest, but also to the
abdomen and pelvis. Although the incidence of seed
migration to the abdomen and pelvis was lower than
that of seed migration to the chest, it would be advisable
to undertake follow-up abdominal and pelvic radio-
graphs after seed implantation. Seed migration to the
chest occurred predominantly within two weeks and,
therefore, it is suggested that follow-up chest radio-
graphs should be undertaken two weeks or later after
seed implantation. Seed migration to the kidneys and
Batson’s vertebral venous plexus was not very rare. Seed
migration did not significantly affect postimplant pros-
tate D90.
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